Provided by Tiger Fintech (Singapore) Pte. Ltd.

Eton Pharmaceuticals, Inc.

14.34
+0.26001.85%
Post-market: 14.340.00000.00%16:05 EDT
Volume:257.21K
Turnover:3.64M
Market Cap:384.56M
PE:-97.13
High:14.50
Open:14.16
Low:13.53
Close:14.08
Loading ...

B.Riley Financial Remains a Buy on Eton Pharmaceuticals (ETON)

TIPRANKS
·
Yesterday

Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Has Found A Path To Profitability

Simply Wall St.
·
15 Apr

BUZZ-Eton Pharma falls after co licenses rare disease drug to Spanish company

Reuters
·
01 Apr

Craig-Hallum Sticks to Their Buy Rating for Eton Pharmaceuticals (ETON)

TIPRANKS
·
01 Apr

Eton Pharmaceuticals Agrees to License International Rights for Increlex to Esteve Pharmaceuticals

MT Newswires Live
·
01 Apr

BRIEF-Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing

Reuters
·
01 Apr

Eton Pharmaceuticals Inc - Esteve Has Option to Acquire International Rights to Increlex for EUR6 Million - SEC Filing

THOMSON REUTERS
·
01 Apr

BRIEF-ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USA

Reuters
·
01 Apr

Esteve: Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights for Increlex, Except for USA

THOMSON REUTERS
·
01 Apr

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

GlobeNewswire
·
01 Apr

Eton Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
20 Mar

Eton Pharmaceuticals Price Target Raised to $24.00/Share From $21.00 by B. Riley Securities

Dow Jones
·
19 Mar

Eton Pharmaceuticals price target raised to $26 from $23 at Craig-Hallum

TIPRANKS
·
19 Mar

B. Riley Raises Price Target on Eton Pharmaceuticals to $24 From $21, Keeps Buy Rating

MT Newswires Live
·
19 Mar

Eton Pharmaceuticals Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
19 Mar

BUZZ-Eton Pharma falls after fourth-quarter loss

Reuters
·
19 Mar

Eton Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
18 Mar

Eton Pharmaceuticals Q4 2024 GAAP EPS $(0.02) Vs. $(0.09) YoY, Sales $11.65M Beat $10.53M Estimate

Benzinga
·
18 Mar

BRIEF-Eton Pharmaceuticals Q4 Net Income USD -598 Thousand

Reuters
·
18 Mar